Zhejiang Huakang Pharmaceutical Co., Ltd.SSE: 605077

Announcement on Holding the Investor Briefing on Terminating Major Asset Restructuring

· Issued by Zhejiang Huakang Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · · 2 pages · Chinese

Summary by 6ix AI

Zhejiang Huakang Pharmaceutical Co., Ltd. announced an investor briefing regarding the termination of a major asset restructuring. The meeting is scheduled to take place online at the Shanghai Stock Exchange's Roadshow Center. The company aims to enhance communication with investors by addressing common concerns during the session. Participants will include key executives from the company, and investors can submit questions prior to the meeting.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Release

Announcement on Holding the Investor Briefing on Terminating Major Asset Restructuring

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Zhejiang Huakang Pharmaceutical Co., Ltd. on 6ix

Earlier from Zhejiang Huakang Pharmaceutical

Later from Zhejiang Huakang Pharmaceutical

All Zhejiang Huakang Pharmaceutical news releases